Teveten Hct Oral Tablet 600-12.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Teveten HCT: Oral tablet (600-12.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_6504.JPG
Teveten HCT 600-12.5mg Tab
Biovail Pharmaceuticals Inc
Pill Identification: 5147  |  SOLVAY
Drug Image file DrugItem_3745.JPG
Teveten HCT 600-12.5mg Tab
Biovail Pharmaceuticals Inc
Pill Identification: 5147  |  SOLVAY
Drug Image file DrugItem_8170.JPG
Teveten HCT 600-12.5mg Tab
AbbVie US LLC formerly Abbott Pharmaceutical Product Division
Pill Identification: SOLVAY  |  5147
Drug Image file DrugItem_8779.JPG
Teveten HCT 600-12.5mg Tab
AbbVie US LLC formerly Abbott Pharmaceutical Product Division
Pill Identification: SOLVAY  |  5147
Drug Image file DrugItem_10649.JPG
Teveten HCT 600-12.5mg Tab
AbbVie US LLC formerly Abbott Pharmaceutical Product Division
Pill Identification: 5147,SOLVAY  |  5147

What is this Medicine?

EPROSARTAN; HYDROCHLOROTHIAZIDE (ep roe SAR tan; hye droe klor oh THYE a zide) is a combination of a drug that relaxes blood vessels and a diuretic. It is used to treat high blood pressure.

In-Depth Information
Select a Medication

Teveten HCT 600mg-12.5mg Tablet

NDC: 000743015
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hypertension

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Teveten HCT 600mg-12.5mg Tablet
Drug Image file DrugItem_10649.JPG
AbbVie US LLC formerly Abbott Pharmaceutical Product Division
Pill Identification: 5147,SOLVAY  |  5147
Shape: oblong
Color: beige

Reported Side Effects for Teveten HCT 600mg-12.5mg Tablet

Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Rash With Pustules Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Diaphoresis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Boils Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Elevated Hepatic Enzymes Incidence:
0.1%*
Severity: MODERATE
Onset: DELAYED
High Potassium Level Incidence:
0.9%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
1.3%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
1.5-3.5%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
4.1%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Teveten HCT 600mg-12.5mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Teveten HCT 600mg-12.5mg Tablet(Hydrochlorothiazide)
Alcohol and Antihypertensives(Hydrochlorothiazide)
Although an interaction is possible, Ethanol (alchohol) and Antihypertensive Agents (drugs used to reduce high blood pressure) may be used together. Ethanol or alchohol-containing beverages may increase the effects of Antihypertensive Agents on your blood pressure. If the blood pressure drops too low while taking Ethanol and Antihypertensive Agents, you may become dizzy or feel faint. To limit this interaction, avoid alcohol-containing beverages while taking medicines to lower your blood pressure. Do not stand or sit up too quickly. Contact your prescriber if you have dizziness which does not go away.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Teveten HCT

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5